NEW YORK (GenomeWeb News) – UCB today announced a two-year partnership with Imperial College London to identify master genetic regulators of brain networks that underlie epileptic activity.

The collaboration, UCB said, may result in the discovery of new drug targets and is the first time that cutting edge technologies, such as RNA sequencing and genome-wide approaches, will be applied to translational epilepsy research.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.